rs72773422
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001038603.3(MARVELD2):c.898T>A(p.Leu300Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00197 in 1,614,208 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L300L) has been classified as Likely benign.
Frequency
Consequence
NM_001038603.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARVELD2 | NM_001038603.3 | c.898T>A | p.Leu300Met | missense_variant | 2/7 | ENST00000325631.10 | NP_001033692.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARVELD2 | ENST00000325631.10 | c.898T>A | p.Leu300Met | missense_variant | 2/7 | 1 | NM_001038603.3 | ENSP00000323264 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00161 AC: 245AN: 152196Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00167 AC: 420AN: 251494Hom.: 2 AF XY: 0.00157 AC XY: 213AN XY: 135922
GnomAD4 exome AF: 0.00201 AC: 2943AN: 1461894Hom.: 6 Cov.: 35 AF XY: 0.00199 AC XY: 1448AN XY: 727248
GnomAD4 genome AF: 0.00161 AC: 245AN: 152314Hom.: 1 Cov.: 32 AF XY: 0.00141 AC XY: 105AN XY: 74478
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 26, 2019 | This variant is associated with the following publications: (PMID: 25885414) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 30, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | MARVELD2: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 12, 2018 | - - |
Autosomal recessive nonsyndromic hearing loss 49 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 23, 2017 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 26, 2015 | p.Leu300Met in exon 2 of MARVELD2: This variant is not expected to have clinical significance because it has been identified in 0.3% (178/67708) of European chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs72773422). In addition, 3 species (chicken, duck, and lizard) have a methionine (Met) at this position despite high nearby amino acid conservation, supporting that this change may be tolerated. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at